The Over the Counter (OTC) Drugs report comprises of a lot of features to offer for Pharmaceutical industry which includes general market conditions, trends, inclinations, key players, opportunities, and geographical analysis. It includes a thorough analysis of the Over the Counter (OTC) Drugs market in customer requirements, customer preferences, and the competitive landscape of the overall market. This report emphasizes on changing dynamics, growth-driving factors, restraints, and limitations. This report employs SWOT analysis technique for the assessment of the development of the most remarkable market players. Over the Counter (OTC) Drugs market report offers broader perspective of the market place with its comprehensive market insights and analysis.
Global Over The Counter (OTC) drugs market is rising gradually with a substantial CAGR of 8.7% in the forecast period of 2019-2026. Adoption of OTC drugs by many pharmaceutical companies and usage by general people over prescription drugs brings a great opportunity to the market growth.
According to the Consumer Healthcare Products Association, the use of OTCs has given rise to the allergy sufferers from 66% (2009) to 75% (2015). An estimated to 81% of adults prefer to use OTC medications as primary option for minor diseases and conditions.
Over The Counter (OTC) drugs are medications that can be taken without the consultation from healthcare professionals by the general public based on the safety and efficacy of the drugs. Some examples of OTC drugs are acetaminophen (paracetamol) and ibuprofen for pain relief, dextromethorphan and cough suppressants. These drugs are safe and effective and are used for the treatment of conditions that do not require the direct consultation of any doctor. OTC drugs are available in all pharmacies and others places such as grocery stores and gas stations.
Key Market Players: Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Sanofi, F. Hoffmann-La Roche Ltd, Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Novartis AG, Sun Pharmaceutical Industries Ltd., Alkem Labs, Reckitt Benckiser Group plc., Piramal Enterprises Ltd., , Cipla, Pfizer Inc., Procter & Gamble, Perrigo Company plc, Mylan N.V., DAIICHI SANKYO COMPANY, LIMITED among others.
Get Sample Copy of this [email protected] https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-over-the-counter-otc-drugs-market
Segmentation: Global Over the Counter (OTC) Drugs Market
By Products Type
- Cold, Cough & Flu Products
- Gastrointestinal Products
- Ophthalmic Products
- Dermatology Products
By End Users
- Specialty Clinics
By Distribution Channels
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- North America
- South America
- Middle East & Africa
Request for Detailed TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-over-the-counter-otc-drugs-market
Key Developments in the Market:
- In July 2019, Sanofi announced an agreement with F. Hoffmann-La Roche Ltd to get the exclusive OTC rights to Tamiflu, an antiviral drug used for the prevention and treatment of patients with influenza or flu. By this agreement, Sanofi will handle the FDA negotiation for the OTC switch and receive the marketing and distribution rights of Tamiflu in the United States
- In March 2018, GlaxoSmithKline plc purchased 36.5% stake in the Consumer Healthcare Joint Venture from Novartis AG. This agreement provides GlaxoSmithKline plc business of sensodyne toothpaste and over-the-counter pills from Novartis AG. By this deal, GlaxoSmithKline plc will own the OTC business of the company and Novartis AG will be enabled to focus on its core businesses
Global over the counter (OTC) drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of over the counter (OTC) drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
- Favorable regulatory policies and conditions for approval of OTC drugs will boost the market growth in the forecast period
- Increasing geriatric population which is highly susceptible to several diseases such as joint pain is another factor uplifting the growth of this market
- Affordable cost associated with OTC drugs is a major driver of market growth
- Increasing patent expirations of many drugs resulting in use as OTC drugs drives the market growth
Research Methodology: Global Over the Counter (OTC) Drugs Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
INQUIRE | FOR MORE INFORMATION ON THIS REPORT @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-over-the-counter-otc-drugs-market
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Email: [email protected]